Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Struvite stone is a type of kidney stone composed mainly of magnesium ammonium phosphate (MgNH_4PO_4·6H_2O), often mixed with carbonate-apatite. It forms in alkaline urine during chronic or recurrent urinary tract infections caused by urease-producing bacteria (such as Proteus, Klebsiella, and others). These stones can grow rapidly, sometimes filling much of the renal collecting system (as "staghorn calculi"), and are associated with significant morbidity including urinary obstruction, infection, and renal injury. Management requires both eradication of infection and removal or dissolution of the stone.
Acetohydroxamic acid inhibits urease enzyme in causative bacteria, decreasing ammonia production and stone formation; antibiotics eradicate causative bacteria to remove infectious nidus
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Struvite stone.